Mostrar el registro sencillo del ítem

dc.creatorXenoulis P.G.en
dc.date.accessioned2023-01-31T11:37:37Z
dc.date.available2023-01-31T11:37:37Z
dc.date.issued2019
dc.identifier10.1002/9781119376293.ch116
dc.identifier.isbn9781119376293; 9781119376347
dc.identifier.urihttp://hdl.handle.net/11615/80838
dc.description.abstractThis chapter presents information on etiology/pathophysiology, signalment/history, clinical features, differential diagnosis, diagnostics and therapeutics of hepatic lipidosis (HL) in dogs and cats. HL is seen very commonly in cats; very rarely, it can also affect dogs. Most cats are middle aged but age of affected cats ranges from one to 16 years. It is important to recognize that the diseases, including primary hepatic disease, can coexist with HL and findings might reflect both conditions and confuse the clinician. Hepatomegaly and diffuse hyperechoic hepatic parenchyma are consistent findings and reflect hepatic lipid accumulation. Feeding an appropriate diet in adequate amounts, via feeding tube, and correction of hypoperfusion and electrolyte disturbances are the cornerstones of treatment. The vast majority of cats with HL need to be hospitalized for some period of time, especially those with severe clinical signs (e.g., if recumbent or with neck ventroflexion); when stabilized, cats can be discharged for home care. © 2019 John Wiley & Sons, Inc.en
dc.language.isoenen
dc.sourceBlackwell’s Five-Minute Veterinary Consult Clinical Companion: Small Animal Gastrointestinal Diseasesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85101425532&doi=10.1002%2f9781119376293.ch116&partnerID=40&md5=32c1b7439fccb1835495e837e44fc1f3
dc.subjectwileyen
dc.titleHepatic lipidosisen
dc.typebookChapteren


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem